Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional

Daniel S Chen1, Yoav Soen, Tor B Stuge

  • 1Department of Internal Medicine/Division of Oncology, Stanford University, Stanford, California, United States of America.

Plos Medicine
|September 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade.

Cell·2026
Same author

A meta-analytic review of cultural variation in affect valuation.

Psychological bulletin·2026
Same author

Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1<sup>+</sup>CD8<sup>+</sup> T cells.

Nature immunology·2024
Same author

Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8<sup>+</sup> T cells.

Cancer cell·2024

Analyzing T cell responses in melanoma patients revealed varied cytokine secretion profiles. Patients with dual secretion of interferon-gamma and tumor necrosis factor-alpha showed better outcomes in a peptide vaccine trial.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Cancer immunotherapy outcomes vary widely in human trials, unlike animal models.
  • Understanding T cell responses is crucial for predicting immunotherapy effectiveness.

Purpose of the Study:

  • To develop a high-throughput method for analyzing T cell responses in melanoma patients undergoing peptide vaccination.
  • To correlate T cell functional profiles with clinical outcomes.

Main Methods:

  • Developed a method using peptide-major histocompatibility complexes (pMHC) arrays and cytokine-capturing antibodies.
  • Enabled simultaneous isolation and multiparametric functional characterization of antigen-specific T cells.
  • Analyzed CD8+ lymphocytes from ten melanoma patients post-vaccination.

Related Experiment Videos

Main Results:

  • Observed diverse patient- and antigen-specific cytokine secretion profiles.
  • Four patients with robust interferon-gamma (IFNgamma) and tumor necrosis factor-alpha (TNFalpha) secretion to gp100 antigen remained recurrence-free.
  • Two of six patients with discordant IFNgamma and TNFalpha secretion were recurrence-free.

Conclusions:

  • Multiparametric T cell analysis is valuable for understanding immune responsiveness.
  • Correlating T cell specificity and function with clinical outcomes aids in dissecting immunotherapy mechanisms.